15-keto-13-14-dihydroprostaglandin-f2alpha and Diarrhea

15-keto-13-14-dihydroprostaglandin-f2alpha has been researched along with Diarrhea* in 2 studies

Reviews

1 review(s) available for 15-keto-13-14-dihydroprostaglandin-f2alpha and Diarrhea

ArticleYear
Prostaglandins as mediators of paraneoplastic syndromes: review and up-date.
    Metabolism: clinical and experimental, 1981, Volume: 30, Issue:3

    Topics: Apudoma; Diarrhea; Dinoprost; Fever; Fingers; Foot Diseases; Humans; Hypercalcemia; Hypotension; Paraneoplastic Syndromes; Polycythemia; Prostaglandins; Prostaglandins E; Prostaglandins F

1981

Other Studies

1 other study(ies) available for 15-keto-13-14-dihydroprostaglandin-f2alpha and Diarrhea

ArticleYear
Plasma prostaglandin levels in radiation-induced enteritis.
    International journal of radiation oncology, biology, physics, 1982, Volume: 8, Issue:2

    Increased prostaglandin synthesis has been implicated as a causative factor in the production of radiation induced enteritis. Seventeen patients selected to begin pelvic irradiation for treatment of gynecological cancer had plasma Prostaglandin E, Prostaglandin F, and 13, 14 dihydro 15 keto PGF2 alpha metabolite determined by radioimmunoassay, prior to initiation of radiotherapy, at weekly intervals during treatment and at six weeks following completion of radiotherapy. A total of 362 prostaglandin determinations were performed. Thirteen patients (76%) developed significant diarrhea consisting of three or more watery bowel movements per day. Nine patients (53%) had intermittent colicky pain and six patients (35%) had nausea and vomiting during treatment. Statistical evaluation revealed no significant elevation of plasma prostaglandins during radiotherapy.

    Topics: Adult; Diarrhea; Dinoprost; Enteritis; Female; Genital Neoplasms, Female; Humans; Middle Aged; Prostaglandins E; Prostaglandins F; Radioimmunoassay; Radiotherapy; Radiotherapy Dosage

1982